Phase II study of high dose weekly intravenous human lymphoblastoid interferon in renal cell carcinoma. A study of the National Cancer Institute of Canada Clinical Trials Group

Br J Cancer. 1987 May;55(5):541-2. doi: 10.1038/bjc.1987.110.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Bone Neoplasms / secondary
  • Carcinoma, Renal Cell / drug therapy*
  • Drug Administration Schedule
  • Drug Evaluation
  • Female
  • Humans
  • Infusions, Intravenous
  • Interferon Type I / administration & dosage*
  • Interferon Type I / therapeutic use
  • Kidney Neoplasms / drug therapy*
  • Liver Neoplasms / secondary
  • Lung Neoplasms / secondary
  • Male
  • Middle Aged
  • Time Factors

Substances

  • Interferon Type I